Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03779243 · ClinicalTrials.gov registry record · NA

Treatment for Sleep Disturbance in Orthopaedic Trauma Patients

A NA study of Trauma and Sleep Disturbance, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT03779243 is a NA study of Trauma and Sleep Disturbance that has completed, run by Stanford University. The registered enrollment target is 90 participants, below the 306-participant average among 56 other Trauma trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03779243, a NA study of Trauma and Sleep Disturbance, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to test the efficacy of sleep treatment in human patients following traumatic injury. Specifically, the study will determine if treatment consisting of melatonin and education related to sleep habits are effective in treating sleep disturbance and improving sleep quality in Orthopaedic trauma patients. We hope to learn if melatonin and sleep education effectively improve sleep following traumatic injury, and improve outcomes.

Conditions Studied

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Melatonin 5mg and Sleep Education

Study Locations (1)

California

  • Stanford - Stanford

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2019-01-07
Est. Completion 2021-08-24
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03779243

The ClinicalTrials.gov registry entry for NCT03779243 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 306-participant average among 56 other Trauma trials with a reported enrollment target (71% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Trauma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03779243 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03779243 about?

NCT03779243 is a clinical study titled "Treatment for Sleep Disturbance in Orthopaedic Trauma Patients". The purpose of the study is to test the efficacy of sleep treatment in human patients following traumatic injury. Specifically, the study will determine if treatment consisting of melatonin and education related to sleep habits are effective in treating sleep disturbance and improving sleep quality ...

What is the current status of trial NCT03779243?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2019-01-07. Estimated completion is 2021-08-24.

What conditions does trial NCT03779243 study?

This clinical trial studies the following conditions: Trauma, Sleep Disturbance.

What interventions are being tested in trial NCT03779243?

The interventions under investigation include: Placebo (OTHER), Melatonin 5mg and Sleep Education (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03779243?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03779243 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.